Observational study / 2007
Consumption of Herbalife products was associated with acute hepatitis and liver injury in a case series of 12 patients in Israel.
Following four index cases, 12 patients with acute idiopathic liver injury associated with Herbalife consumption were investigated across Israeli hospitals. Eleven patients were female (mean age 49.5+/-13.4 years), and acute liver injury was diagnosed 11.9+/-11.1 months after initiating Herbalife products. One patient developed sub-fulminant and two developed fulminant hepatic failure; one died from liver transplantation complications while 11 recovered. Three patients who resumed Herbalife after normalization of liver enzymes suffered a second bout of hepatitis.
Shows an association, not proof of cause and effect.
- Study type
- Case series / outbreak investigation
- Who was studied
- 12 patients with acute idiopathic liver injury consuming Herbalife products in Israel
- What was measured
- Acute hepatotoxicity, liver histology, and clinical outcomes
THE PAPER
Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity.
Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, Keinan-Boker L, Broide E, Ackerman Z, Kaluski DN, Lev B, Shouval D. J Hepatol, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.